251 related articles for article (PubMed ID: 4182059)
1. Antinuclear antibody induced by procainamide. A prospective study.
Blomgren SE; Condemi JJ; Bignall MC; Vaughan JH
N Engl J Med; 1969 Jul; 281(2):64-6. PubMed ID: 4182059
[No Abstract] [Full Text] [Related]
2. Occurrence, immunoglobulin pattern and specificity of antinuclear antibodies in sera of procaine amide treated patients.
Klajman A; Camin-Belsky N; Kimchi A; Ben-Efraim S
Clin Exp Immunol; 1970 Nov; 7(5):641-9. PubMed ID: 4099667
[TBL] [Abstract][Full Text] [Related]
3. Drug-induced lupus erythematosus syndrome. Immuno-pathological, electronmicroscopical and serological studies.
Ullman S; Wiik A; Kobayasi T; Halberg P
Acta Derm Venereol; 1974; 54(5):387-90. PubMed ID: 4138086
[No Abstract] [Full Text] [Related]
4. [Immunoglobulins and autoantibodies. (Characterization studies of some autoantibodies and clinical observations)].
Bonomo L
G Mal Infett Parassit; 1966 Dec; 18(12):Suppl:993-1004. PubMed ID: 4173183
[No Abstract] [Full Text] [Related]
5. The frequency of procainamide-induced systemic lupus erythematosus.
Hope RR; Bates LA
Med J Aust; 1972 Aug; 2(6):298-303. PubMed ID: 4117237
[No Abstract] [Full Text] [Related]
6. Complement-fixing activity of antinuclear antibodies induced by procaine amide treatment.
Klajman A; Farkas R; Ben-Efraim S
Isr J Med Sci; 1973 May; 9(5):627-30. PubMed ID: 4123966
[No Abstract] [Full Text] [Related]
7. Treatment of systemic lupus erythematosus (SLE) with immunosuppressive drugs 1: An analysis of immunologic data.
Cruchaud A; Pometta D; Rousso C
Helv Med Acta; 1967 Dec; 34(1):5-22. PubMed ID: 4173836
[No Abstract] [Full Text] [Related]
8. [Determination of the immunoglobulin type of complement fixing and non-fixing anti-nuclear factors].
Peltier AP; Strejcek G
Rev Fr Etud Clin Biol; 1969 Oct; 14(8):787-95. PubMed ID: 4189485
[No Abstract] [Full Text] [Related]
9. Qualitative and quantitative abnormalities of immunoglobulins in relatives of patients with idiopathic paraprotenemia. A study of 12 families.
Petite J; Cruchaud A
Helv Med Acta; 1970 Oct; 35(4):248-65. PubMed ID: 4097006
[No Abstract] [Full Text] [Related]
10. Drug-induced pulmonary disease.
Winkler JW
Ann Intern Med; 1973 Apr; 78(4):617. PubMed ID: 4540389
[No Abstract] [Full Text] [Related]
11. Lupus-like syndrome induced by procainamide.
Fakhro AM; Ritchie RF; Lown B
Am J Cardiol; 1967 Sep; 20(3):367-73. PubMed ID: 4166916
[No Abstract] [Full Text] [Related]
12. Serum antinuclear antibodies in progressive systemic sclerosis (scleroderma).
Rothfield NF; Rodnan GP
Arthritis Rheum; 1968 Oct; 11(5):607-17. PubMed ID: 4176069
[No Abstract] [Full Text] [Related]
13. [The reversible procaine amide-induced lupus-erythromatosus syndrome].
Günther R; Asamer H; Dittrich P
Dtsch Med Wochenschr; 1969 Nov; 94(45):2338-42. PubMed ID: 4186711
[No Abstract] [Full Text] [Related]
14. [Some aspects of humoral and cellular immunity in acute viral hepatitis. Diagnostic and prognostic prospects].
Fiaschi E; Naccarato R; Fagiolo U; Farini R
Rev Med Chir Mal Foie; 1970; 45(4):215-26. PubMed ID: 4194748
[No Abstract] [Full Text] [Related]
15. Cold-insoluble complexes and complement levels in systemic lupus erythematosus.
Stastny P; Ziff M
N Engl J Med; 1969 Jun; 280(25):1376-81. PubMed ID: 4181609
[No Abstract] [Full Text] [Related]
16. A familial study of procainamide-induced systemic lupus erythematosus. A question of pharmacogenetic polymorphism.
Lappat EJ; Cawein MJ
Am J Med; 1968 Dec; 45(6):846-52. PubMed ID: 4177546
[No Abstract] [Full Text] [Related]
17. Immunoglobulins, basic myelin proteins and age in man and monkeys.
Felsenfeld O; Wolf H
Ann Immunol Hung; 1972; 16(0):123-9. PubMed ID: 4137718
[No Abstract] [Full Text] [Related]
18. [Procainamide- and quinidine-induced immunological changes].
Oka M; Räsänen J; Häkkinen P
Duodecim; 1977; 93(3):206-12. PubMed ID: 300324
[No Abstract] [Full Text] [Related]
19. [Abnormal findings in the blood in SLE].
Ofuji T; Miyawaki S; Sato H; Morita M; Nishishita S
Nihon Rinsho; 1968 Dec; 26(12):3449-58. PubMed ID: 4181084
[No Abstract] [Full Text] [Related]
20. Effect of acetylator phenotype on the rate at which procainamide induces antinuclear antibodies and the lupus syndrome.
Woosley RL; Drayer DE; Reidenberg MM; Nies AS; Carr K; Oates JA
N Engl J Med; 1978 May; 298(21):1157-9. PubMed ID: 306574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
